Stem Cell-Derived Models in Toxicology:
This detailed volume brings together a diverse collection of stem cell-derived model-based toxicity assays, from those routinely used to those deemed to have considerable potential. With a focus on differentiated tissues, the chapters explore numerous cardiotoxicity applications as well as coverage...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Springer New York
2017
|
| Schriftenreihe: | Methods in Pharmacology and Toxicology
|
| Schlagworte: | |
| Online-Zugang: | UBR01 TUM01 Volltext |
| Zusammenfassung: | This detailed volume brings together a diverse collection of stem cell-derived model-based toxicity assays, from those routinely used to those deemed to have considerable potential. With a focus on differentiated tissues, the chapters explore numerous cardiotoxicity applications as well as coverage of neurotoxicity, hepatotoxicity, and more. Written for the Methods in Pharmacology and Toxicology series, the contents of this book aim to enable adoption of these protocols in laboratories that are interested in entering the field as well as to facilitate the transfer of best practices between laboratories that are already actively pursuing these technologies. Authoritative and cutting-edge, Stem Cell-Derived Models in Toxicology serves as a vital resource for researchers aiming to improve risk assessment in drug discovery and design |
| Beschreibung: | 1 Online-Ressource (XII, 341 p. 124 illus., 108 illus. in color) |
| ISBN: | 9781493966615 |
| DOI: | 10.1007/978-1-4939-6661-5 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044951497 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180517s2017 |||| o||u| ||||||eng d | ||
| 020 | |a 9781493966615 |9 978-1-4939-6661-5 | ||
| 024 | 7 | |a 10.1007/978-1-4939-6661-5 |2 doi | |
| 035 | |a (ZDB-2-PRO)978-1-4939-6661-5 | ||
| 035 | |a (OCoLC)965700324 | ||
| 035 | |a (DE-599)BVBBV044951497 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-91 | ||
| 082 | 0 | |a 615 |2 23 | |
| 245 | 1 | 0 | |a Stem Cell-Derived Models in Toxicology |c edited by Mike Clements, Liz Roquemore |
| 264 | 1 | |a New York, NY |b Springer New York |c 2017 | |
| 300 | |a 1 Online-Ressource (XII, 341 p. 124 illus., 108 illus. in color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Methods in Pharmacology and Toxicology | |
| 520 | |a This detailed volume brings together a diverse collection of stem cell-derived model-based toxicity assays, from those routinely used to those deemed to have considerable potential. With a focus on differentiated tissues, the chapters explore numerous cardiotoxicity applications as well as coverage of neurotoxicity, hepatotoxicity, and more. Written for the Methods in Pharmacology and Toxicology series, the contents of this book aim to enable adoption of these protocols in laboratories that are interested in entering the field as well as to facilitate the transfer of best practices between laboratories that are already actively pursuing these technologies. Authoritative and cutting-edge, Stem Cell-Derived Models in Toxicology serves as a vital resource for researchers aiming to improve risk assessment in drug discovery and design | ||
| 650 | 4 | |a Biomedicine | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Pharmacology | |
| 700 | 1 | |a Clements, Mike |4 edt | |
| 700 | 1 | |a Roquemore, Liz |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781493966592 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4939-6661-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-PRO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030344255 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4939-6661-5 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-1-4939-6661-5 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804178540165332992 |
|---|---|
| any_adam_object | |
| author2 | Clements, Mike Roquemore, Liz |
| author2_role | edt edt |
| author2_variant | m c mc l r lr |
| author_facet | Clements, Mike Roquemore, Liz |
| building | Verbundindex |
| bvnumber | BV044951497 |
| collection | ZDB-2-PRO |
| ctrlnum | (ZDB-2-PRO)978-1-4939-6661-5 (OCoLC)965700324 (DE-599)BVBBV044951497 |
| dewey-full | 615 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615 |
| dewey-search | 615 |
| dewey-sort | 3615 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4939-6661-5 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02365nmm a2200433zc 4500</leader><controlfield tag="001">BV044951497</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2017 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781493966615</subfield><subfield code="9">978-1-4939-6661-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4939-6661-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-4939-6661-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)965700324</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044951497</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Stem Cell-Derived Models in Toxicology</subfield><subfield code="c">edited by Mike Clements, Liz Roquemore</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer New York</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XII, 341 p. 124 illus., 108 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Pharmacology and Toxicology</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This detailed volume brings together a diverse collection of stem cell-derived model-based toxicity assays, from those routinely used to those deemed to have considerable potential. With a focus on differentiated tissues, the chapters explore numerous cardiotoxicity applications as well as coverage of neurotoxicity, hepatotoxicity, and more. Written for the Methods in Pharmacology and Toxicology series, the contents of this book aim to enable adoption of these protocols in laboratories that are interested in entering the field as well as to facilitate the transfer of best practices between laboratories that are already actively pursuing these technologies. Authoritative and cutting-edge, Stem Cell-Derived Models in Toxicology serves as a vital resource for researchers aiming to improve risk assessment in drug discovery and design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Clements, Mike</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roquemore, Liz</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781493966592</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4939-6661-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030344255</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-6661-5</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-6661-5</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044951497 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:05:35Z |
| institution | BVB |
| isbn | 9781493966615 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030344255 |
| oclc_num | 965700324 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (XII, 341 p. 124 illus., 108 illus. in color) |
| psigel | ZDB-2-PRO |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Springer New York |
| record_format | marc |
| series2 | Methods in Pharmacology and Toxicology |
| spelling | Stem Cell-Derived Models in Toxicology edited by Mike Clements, Liz Roquemore New York, NY Springer New York 2017 1 Online-Ressource (XII, 341 p. 124 illus., 108 illus. in color) txt rdacontent c rdamedia cr rdacarrier Methods in Pharmacology and Toxicology This detailed volume brings together a diverse collection of stem cell-derived model-based toxicity assays, from those routinely used to those deemed to have considerable potential. With a focus on differentiated tissues, the chapters explore numerous cardiotoxicity applications as well as coverage of neurotoxicity, hepatotoxicity, and more. Written for the Methods in Pharmacology and Toxicology series, the contents of this book aim to enable adoption of these protocols in laboratories that are interested in entering the field as well as to facilitate the transfer of best practices between laboratories that are already actively pursuing these technologies. Authoritative and cutting-edge, Stem Cell-Derived Models in Toxicology serves as a vital resource for researchers aiming to improve risk assessment in drug discovery and design Biomedicine Pharmacology/Toxicology Medicine Pharmacology Clements, Mike edt Roquemore, Liz edt Erscheint auch als Druck-Ausgabe 9781493966592 https://doi.org/10.1007/978-1-4939-6661-5 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Stem Cell-Derived Models in Toxicology Biomedicine Pharmacology/Toxicology Medicine Pharmacology |
| title | Stem Cell-Derived Models in Toxicology |
| title_auth | Stem Cell-Derived Models in Toxicology |
| title_exact_search | Stem Cell-Derived Models in Toxicology |
| title_full | Stem Cell-Derived Models in Toxicology edited by Mike Clements, Liz Roquemore |
| title_fullStr | Stem Cell-Derived Models in Toxicology edited by Mike Clements, Liz Roquemore |
| title_full_unstemmed | Stem Cell-Derived Models in Toxicology edited by Mike Clements, Liz Roquemore |
| title_short | Stem Cell-Derived Models in Toxicology |
| title_sort | stem cell derived models in toxicology |
| topic | Biomedicine Pharmacology/Toxicology Medicine Pharmacology |
| topic_facet | Biomedicine Pharmacology/Toxicology Medicine Pharmacology |
| url | https://doi.org/10.1007/978-1-4939-6661-5 |
| work_keys_str_mv | AT clementsmike stemcellderivedmodelsintoxicology AT roquemoreliz stemcellderivedmodelsintoxicology |